Sustained improvement of clinical CNS and somatic features of Gaucher disease type 3 after haematopoietic stem cell (HSC) gene therapy: A first-in-world report

被引:1
作者
Donald, Aimee [1 ]
Potter, Jane [2 ]
Church, Heather J. [3 ]
Amirloo, Bahareh [4 ]
Cooper, James [5 ]
Egerton, Christine [5 ]
Watts, Kelly E. [6 ]
Hutton, Rebekah A. [7 ]
Rust, Stewart [8 ]
Bromley, Rebecca [9 ]
Stivaros, Stavros M. [10 ]
Adera, Mathews [11 ]
Ridha, Essra [11 ]
Veselinovic, Milena [12 ]
Jones, Simon A. [13 ]
Wynn, Robert [14 ]
Broomfield, Alexander [15 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Manchester, England
[2] Royal Manchester Childrens Hosp, Manchester, England
[3] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Willink Biochem Genet Unit, Manchester, England
[4] Manchester Univ NHS Fdn Trust, Pharm, Manchester, England
[5] Manchester Fdn Trust, Willink Biochem Ctr, St Marys Hosp, Manchester, England
[6] Manchester Fdn Trust, R&I, Manchester, England
[7] St Marys Hosp, Willink Unit Metabol, Manchester, England
[8] Royal Manchester Childrens Hosp, Psychol, Manchester, England
[9] Univ Manchester, Manchester, England
[10] Royal Manchester Childrens Hosp, Radiol, Manchester, England
[11] Avrobio, Cambridge, MA USA
[12] AVROBIO, Clin Dev, Cambridge, MA USA
[13] St Marys Hosp, Manchester Ctr Genom Med, Manchester, England
[14] Royal Manchester Childrens Hosp, Stem Cell Transplant, Manchester, England
[15] Royal Manchester Childrens Hosp, Biochem Genet, Manchester, England
关键词
D O I
10.1016/j.ymgme.2022.107083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
100
引用
收藏
页码:36 / 37
页数:2
相关论文
empty
未找到相关数据